Oral Mucositis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Oral Mucositis Clinical Trial Report Overview

A total of 506 Oral Mucositis clinical trials were conducted as of December 2023. The Oral Mucositis clinical trial report provides a comprehensive understanding of the Oral Mucositis clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials.

Key Regions ·        Asia-Pacific

·        Europe

·        North America

·        Middle East and Africa

·        South and Central America

Key Countries ·        Iran

·        United States

·        China

·        Japan

·        India

·        United Kingdom

·        Germany

Key Sponsor Types ·        Company

·        Institution

·        Government

Leading Sponsors ·        Amgen Inc

·        Swedish Orphan Biovitrum AB

·        Galera Therapeutics Inc

·        Alizyme plc (Inactive)

·        GSK plc

·        Mallinckrodt Plc

·        Jazz Pharmaceuticals Plc

·        Novartis AG

·        Others

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Oral Mucositis Clinical Trials Segmentation by Regions and Countries

Asia-Pacific led the Oral Mucositis clinical trials landscape with more than 30% of the clinical trials conducted as of December 2023.

The key regions considered for Oral Mucositis clinical trials analysis are Asia-Pacific, Europe, North America, the Middle East and Africa, and South and Central America.

In the country-wise analysis, Iran and the US had the highest number of oral mucositis clinical trials, as of December 2023. China had the highest average patient enrollment of oral mucositis clinical trials, as of December 2023.

G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, Japan accounted for the highest proportion of Oral Mucositis to Gastrointestinal clinical trials as of December 2023.

E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Brazil accounted for the highest proportion of Oral Mucositis to Gastrointestinal clinical trials as of December 2023.

Oral Mucositis Clinical Trials Analysis by Regions, 2023 (%)

Oral Mucositis Clinical Trials Analysis by Regions, 2023 (%)

Buy the Full Report for More Regional Insights into the Oral Mucositis Clinical Trials

Download a Free Sample Report

Oral Mucositis Clinical Trials Segmentation by Sponsor Types

The key sponsor types for Oral Mucositis clinical trials are company, institution, and the government. As of December 2023, more than 67% of Oral Mucositis clinical trials conducted were sponsored by institution sponsor type, followed by the company.

Oral Mucositis Clinical Trials Analysis by Sponsor Type, 2023 (%)

Oral Mucositis Clinical Trials Analysis by Sponsor Type, 2023 (%)

Buy the Full Report for More Insights into the Oral Mucositis Clinical Trials Sponsor Types

 Download a Free Sample Report

Oral Mucositis Clinical Trials - Competitive Landscape

In 2023, Amgen Inc conducted the highest number of Oral Mucositis clinical trials.

A few of the leading sponsors for Oral Mucositis clinical trials are:

  • Amgen Inc
  • Swedish Orphan Biovitrum AB
  • Galera Therapeutics Inc
  • Alizyme plc (Inactive)
  • GSK plc
  • Mallinckrodt Plc
  • Jazz Pharmaceuticals Plc
  • Novartis AG

Oral Mucositis Clinical Trials Analysis by Leading Companies, 2023 (%)

Oral Mucositis Clinical Trials Analysis by Leading Companies, 2023 (%)

Buy Full Report to Know More About the Leading Players of Oral Mucositis Clinical Trials

 Download a Free Sample Report

Segments Covered in the Report

Oral Mucositis Clinical Trials Regional Outlook (2023)

  • Asia-Pacific
  • Europe
  • North America
  • Middle East and Africa
  • South and Central America

Oral Mucositis Clinical Trials Country Outlook (2023)

  • Iran
  • United States
  • China
  • Japan
  • India
  • United Kingdom
  • Germany

Oral Mucositis Clinical Trials Sponsor Type Outlook (2023)

  • Company
  • Institution
  • Government

Scope

  • The report provides a snapshot of the global clinical trials landscape.
  • The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
  • The report reviews the top companies involved and enlists all trials (trial title, phase, and status) of the company.
  • The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for accomplishment.
  • The report provides enrollment trends for the past five years.
  • The report provides the latest news for the past three months.

Reasons to Buy

  • Assists in formulating key investment strategies.
  • Helps in identifying time-saving and cost-efficient locations to conduct clinical trials.
  • Provides top-level analysis of the global clinical trials market to help in identifying key business opportunities.
  • Helps in understanding trial count and enrollment trends by country in the global therapeutics market.
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials.
  • Facilitates clinical trial assessment of the indication on a global, regional, and country level.

Table of Contents

  • 1. Table of Contents

    • 1.1. List of Tables
    • 1.2. List of Figures

  • 2. Report Guidance
  • 3. GlobalData Clinical Trials Report Coverage
  • 4. Clinical Trials by Region

    • 4.1. Clinical Trials and Average Enrollment by Country

      • 4.1.1. Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • 4.1.2. Top Five Countries Contributing to Clinical Trials in Europe
      • 4.1.3. Top Countries Contributing to Clinical Trials in North America
      • 4.1.4. Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • 4.1.5. Top Five Countries Contributing to Clinical Trials in Central and South America

  • 5. Clinical Trials by G7 Countries: Proportion of Oral Mucositis to Gastrointestinal Clinical Trials
  • 6. Clinical Trials by Phase in G7 Countries
  • 7. Clinical Trials in G7 Countries by Trial Status
  • 8. Clinical Trials by E7 Countries: Proportion of Oral Mucositis to Gastrointestinal Clinical Trials
  • 9. Clinical Trials by Phase in E7 Countries
  • 10. Clinical Trials in E7 Countries by Trial Status
  • 11. Clinical Trials by Phase

    • 11.1. In Progress Trials by Phase

  • 12. Clinical Trials by Trial Status
  • 13. Clinical Trials by End Point Status
  • 14. Subjects Recruited Over a Period of Time
  • 15. Clinical Trials by Sponsor Type
  • 16. Prominent Sponsors

    • 16.1. Top Companies Participating in Oral Mucositis Therapeutics Clinical Trials

  • 17. Prominent Drugs
  • 18. Clinical Trial Profile Snapshots
  • 19. Appendix

    • 19.1. Abbreviations
    • 19.2. Definitions
    • 19.3. Research Methodology
    • 19.4. Secondary Research
    • 19.5. About GlobalData
    • 19.6. Contact Us

  • 20. Source

Table

Oral Mucositis Therapeutics, Global, Clinical Trials by Region, 2023* 7_x000D_

Oral Mucositis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2023* 9_x000D_

Oral Mucositis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2023* 10_x000D_

Oral Mucositis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2023* 11_x000D_

Oral Mucositis Therapeutics Clinical Trials, Europe, Top Five Countries, 2023* 12_x000D_

Oral Mucositis Therapeutics Clinical Trials, North America, Top Countries, 2023* 13_x000D_

Oral Mucositis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2023* 14_x000D_

Oral Mucositis Therapeutics Clinical Trials, Central and South America, Top Countries, 2023* 15_x000D_

Proportion of Oral Mucositis to Gastrointestinal Clinical Trials, G7 Countries (%), 2023* 17_x000D_

Oral Mucositis Therapeutics, G7 Countries, Clinical Trials by Phase, 2023* 18_x000D_

Oral Mucositis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2023* 20_x000D_

Proportion of Oral Mucositis to Gastrointestinal Clinical Trials, E7 Countries (%), 2023* 21_x000D_

Oral Mucositis Therapeutics, E7 Countries, Clinical Trials by Phase, 2023* 22_x000D_

Oral Mucositis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2023* 24_x000D_

Oral Mucositis Therapeutics, Global, Clinical Trials by Phase, 2023* 25_x000D_

Oral Mucositis Therapeutics, Global, Clinical Trials In Progress by Phase 2023* 26_x000D_

Oral Mucositis Therapeutics, Global, Clinical Trials by Trial Status, 2023* 28_x000D_

Oral Mucositis Therapeutics Clinical Trials, Global, by End Point Status, 2023* 29_x000D_

Oral Mucositis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2018-2022 30_x000D_

Oral Mucositis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2023* 31_x000D_

Oral Mucositis Therapeutics Clinical Trials, Global, Key Sponsors, 2023* 33_x000D_

Oral Mucositis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2023* 35_x000D_

Oral Mucositis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2023* 36

Figures

Oral Mucositis Therapeutics, Global, Clinical Trials by Region (%), 2023* 7_x000D_

Oral Mucositis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2023* 8_x000D_

Oral Mucositis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2023* 10_x000D_

Oral Mucositis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2023* 11_x000D_

Oral Mucositis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2023* 12_x000D_

Oral Mucositis Therapeutics Clinical Trials, North America, Top Countries (%), 2023* 13_x000D_

Oral Mucositis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2023* 14_x000D_

Proportion of Oral Mucositis to Gastrointestinal Clinical Trials, G7 Countries (%), 2023* 16_x000D_

Oral Mucositis Therapeutics, G7 Countries, Clinical Trials by Phase, 2023* 18_x000D_

Oral Mucositis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2023* 19_x000D_

Proportion of Oral Mucositis to Gastrointestinal Clinical Trials, E7 Countries (%), 2023* 21_x000D_

Oral Mucositis Therapeutics, E7 Countries, Clinical Trials by Phase, 2023* 22_x000D_

Oral Mucositis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2023* 23_x000D_

Oral Mucositis Therapeutics, Global, Clinical Trials by Phase (%), 2023* 25_x000D_

Oral Mucositis Therapeutics, Global, Clinical Trials In Progress by Phase, 2023* 26_x000D_

Oral Mucositis Therapeutics, Global, Clinical Trials by Trial Status, 2023* 27_x000D_

Oral Mucositis Therapeutics Clinical Trials, Global, by End Point Status, 2023* 29_x000D_

Oral Mucositis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2018-2022 30_x000D_

Oral Mucositis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2023* 31_x000D_

Oral Mucositis Therapeutics Clinical Trials, Global, Key Sponsors, 2023* 32_x000D_

Oral Mucositis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2023* 34_x000D_

Oral Mucositis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2023* 36_x000D_

GlobalData Methodology 297

Frequently asked questions

Oral Mucositis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update standard reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Oral Mucositis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Pharmaceuticals
New
Insulin Receptor - Drugs In Development, 2024
$3,500 | June 2024
Pharmaceuticals
New
5-Hydroxytryptamine Receptor 2A - Drugs In Development, 2024
$3,500 | June 2024
Pharmaceuticals
New
Mu Type Opioid Receptor - Drugs In Development, 2024
$3,500 | June 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Oral Mucositis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update in real time.

  • Access a live Oral Mucositis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.